Featured Lawsuits

May 4, 2026

Paragard IUD Lawsuit Settlement Amounts

Our lawyers are handling Paragard IUD removal lawsuits in all 50 states. Over 3,500 women have filed a Paragard IUD lawsuit claiming that they were injured when a design defect in the IUD caused it to fracture during removal and leave foreign objects inside their bodies.

These lawsuits allege the Paragard intrauterine device breaks upon removal because it is made with inflexible plastic and degrades before the device expires. Over 3,000 lawsuits have been lodged against Teva Pharmaceutical and CooperSurgical by women who encountered issues such as breakage during removal or implantation, or other complications associated with the Paragard birth control device.

This page provides the latest update on the 2026 Paragard lawsuit. Our lawyers also speculate on the potential settlement value of a Paragard lawsuit if the litigation is resolved through a global settlement with the manufacturers. When could there be a settlement? Soon. These cases could be resolved by the end of 2026, with victims receiving payment in 2026 if the settlement is finalized quickly. Is that the most likely scenario? We are cautiously optimistic, but after the first trial loss in February 2026,

May 1, 2026

Talc Powder Ovarian Cancer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling baby powder lawsuits in all 50 states in 2026. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides an update on J&J talc powder litigation and discusses the settlement amounts in ovarian cancer lawsuits for victims.

Has the deadline passed for you to file a talcum powder lawsuit? Many who assume the statute of limitations has passed to sue Johnson & Johnson may be wrong. But as we write this in January 2026, his settlement has blown up, and we are back at it. We are still signing up new clients, but this may not last much longer. Call us today at 800-553-8082 or get a free and quick case review online.

April 28, 2026

Uber Sexual Assault Lawsuits

by Ronald V. Miller, Jr.

Uber is facing one of the largest waves of passenger sexual assault lawsuits in U.S. history. Survivors across the country allege that Uber drivers sexually assaulted them and that the company is legally responsible because it failed to screen drivers properly, ignored prior complaints, and did not implement basic safety measures.

These claims are now consolidated in In re: Uber Technologies Inc., Passenger Sexual Assault Litigation (MDL No. 3084) in the Northern District of California. As of April 2026, 3,391 plaintiffs in 30 states have joined the MDL, with this number expected to continue rising throughout 2026.

The first MDL trial began in January 2026, and the jury returned an $8.5 million verdict in early February. Our lawyers believe these are exceptionally strong cases. The evidence points to a pattern: repeated warnings about dangerous drivers, no action from Uber, and preventable assaults that followed. In the courtroom, that is the kind of timeline juries understand and respond to. It is also the kind of fact pattern that can lead to substantial Uber sexual assault settlement amounts.

April 28, 2026

Spinal Cord Stimulator Lawsuit

by Ronald V. Miller, Jr.

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many people arrive here with a practical question in mind: what do spinal cord stimulator settlement amounts look like, and how does compensation get calculated when a device causes lasting harm? That question cannot be answered in isolation. Settlement amounts and payouts are driven by the full medical timeline, including the cost of repeat surgeries, explantation, permanent loss of function, and the downstream consequences when a pain-management device leaves someone worse off than before it was implanted.

by Ronald V. Miller, Jr.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.